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Effects of Toxic Substances
on Female Reproduction
by Donald R. Mattison,* Maria S. Nightingale*
and Kenji Shiromizu*
Successful reproduction requires a complex series of interdependent physiological, cellular
and molecular events. In the female many of these interdependent events are vulnerable to
interruption by xenobiotic compounds. The physiological steps in the female reproductive cycle
are reviewed. Selectedxenobiotics which interrupt this cycle are presented and their mechanisms
and site of adverse effects are discussed. Finally, a more detailed discussion of chemically
induced ovarian failure in the human and an experimental animal model system is presented.
Introduction
Successful reproduction in the female requires
the stepwise completion of a complex series of
interdependent events (Fig. 1). Existing evidence
suggests that this reproductive cycle is vulnerable
at manypoints totheadverse influence ofzenobiotic
substances, including drugs and environmental pol-
lutants (1-6). Two additional events not addressed
in Figure 1 which must be considered in a discus-
sion of female reproductive toxicology are the age
of female reproductive senescence and the control
of female fertility.
As the length oftime between sexual maturation
and reproductive senescence directly influences the
potential reproductive capacity of a female, xeno-
biotics which alter the age of sexual maturation or
reproductive senescence mayhave aprofoundimpact
on human reproduction and well-being. At the
present time several drugs, biotics and xenobiotics
have been identified which will produce premature
senescence ofthe female reproductive system (3-5,
7-9). Prepubertal or prenatal exposure to these
compounds may also prevent the onset of puberty
as a direct result of their toxicity (10-14).
The expression of fertility in human populations
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FIGURE 1. Reproductive cycle in the female. This figure repre-
sents a summary of the physiological events required for
successful reproduction. Reprinted from Mattison (4) with
permission.
has considerably greater significance than just
successful functioning of the reproductive system.
The offspring, products of this system, represent
an economic and temporal responsibility for the
parents. Because of this, considerable effort has
been invested in the development of safe and
reliable methods of contraception. Another area of
concern in female reproductive toxicity is therefore
theidentification andcharacterization ofxenobiotics
which impair the mechanism ofaction ofcontracep-
tives. This is especially crucial in situations where
women are exposed to complex mixtures containingMATTISON, NIGHTINGALE AND SHIROMIZU
compounds which decrease the effectiveness of
their chosen contraceptive, and others which act as
teratogens.
Because reproductive toxicology encompasses
reproductive biology and toxicology it is necessary
to consider both the mechanism and site ofaction of
areproductive toxin. This dualapproach isrequired
because of: strain and species differences in repro-
ductive biology; strain and species differences in
toxification, detoxification, and repair of cellular
damage; strain and species differences in sensitive
windows for reproductive toxicity; and strain and
species differences in reproductive end points mon-
itored to assess toxicity. To approach this perspec-
tive we will briefly consider the events necessary
for successful female reproduction and identify
several xenobiotics which interrupt reproduction at
specific sites. We will then present a systematic
approach to organize and understand the diverse
mechanisms of these reproductive toxins. Finally,
we will consider in some detail the mechanism of
action of xenobiotics which produce premature
ovarian failure.
Female Reproduction
Thereproductive events outlined onFigure 1 can
be arbitrarily divided in many ways, one clinically
and experimentally useful division is shown on
Table 1. This framework will allow an overview of
female reproduction and introduction of selected
reproductive toxins.
Table 1. Female reproduction.
Prefertilization
Reproductive system development
Sexual maturation
Ovulation-meiosis-corpus luteum
Hormonal effects
Ovum transport
Sperm transport
Fertilization to implantation
Sperm-egg recognition
Sperm penetration
Sperm nuclear decondensation
Pronuclear interaction
Conceptus transport
Conceptus-endometrium interaction
Placentation to parturition
Endometrial development
Cytotropoblast-syncytiotrophoblast
Placental growth-maturation
Fetal organogenesis
Fetal growth-maturation
Maternal metabolic alteration
Fetal-placental-maternal interaction
Parturition
Fetal-maternal interaction
Uterine electrical and muscular activity
Cervical relaxation
Birth canal
Postnatal
Placental delivery
Uterine involution
Fetal adaptation
Lactation
Maternal metabolic adaptation
Reproductive senescence
Hypothalamic-pituitary failure
Ovarian failure
Uterine failure
Prefertilization
The reproductive processes grouped under pre-
fertilization are quite broad and include develop-
ment of the reproductive system, sexual matura-
tion, gamete release and transport, as well as hor-
monal effects on reproductive organs. Xenobiotics
which alterdevelopment ofthereproductive organs
may have a profound effect on subsequent repro-
ductivefunction. Severalxenobioticcompoundshave
beenidentified which alterdevelopment oftherepro-
ductive system including; diethylstilbesterol, cer-
tain polycyclic aromatic hydrocarbons, punne ana-
logs (azathioprine and 6-mercaptopurine) and gal-
actose.
Diethylstilbesterol (DES) is interesting because
it embodies a mechanistic dilemma and illustrates
the often cryptic nature of reproductive toxins.
DES was introduced into obstetrical practice in the
early 1940s as atherapeutic modalityforpregnancy
wastage. The rationale and effectiveness have been
previously reviewed (4). It was subsequently dis-
covered that this treatment produced vaginal ade-
nocarcinoma in less than 1/1000 women exposed in
utero during the first trimester.
Additionalandcontinuingstudieshaveattempted
to characterize the effects of DES on the structure
and dynamic functioning ofthe female reproductive
system. These studies suggest that prenatal DES
treatmentaltersboththedevelopment andfunction
of the female reproductive system (4). In spite of
the captive nature of the exposed population and
the seemingly well-defined exposure, considerable
disagreement existsregardingthe actualreproduc-
tive toxicity of prenatal DES exposure. This dis-
agreement appears to result in part from the broad
therapeutic protocols used in prescribing the drug.
Patients and controls with well-documented treat-
mentduringthe firsttrimester, such asthe Chicago
Lying-Indouble-blind study, maybethebestgroup
to explore the toxicity of DES.
Galactose and the purine analogs, azathioprine
and 6-mercaptopurine, also alter reproductive sys-
tem development in a very specific way. All three
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compounds produce ovarian toxicity by blocking
some facet of oogenesis (14-16).
Sexual maturation can be altered by several
xenobiotics. Compounds which block oogenesis or
destroy oocytes before puberty leaving the ovary
devoid of follicles will clearly block pubertal pro-
gression. Estrogenagonistsinsufficientlyhighdoses
will produce a precocious pseudopuberty; this may
alsooccurwithcertainhalogenatedpolycyclichydro-
carbons (17-21) and phytoestrogens (22).
Ovulation, resumption of meiosis, and corpus
luteumfunctionaswellassecondaryhormonaleffects
duringthe menstrual cycle depend on dynamic hor-
monal interactions along with hypothalamic-pitui-
tary-ovarian-uterine axis (23). Xenobiotics which
interrupt these dynamic interactions include pesti-
cides, barbiturates, polycyclic aromatic hydrocar-
bons, halogenated aromatic hydrocarbons, and ste-
roid hormone agonists and antagonists (3,24).
Althoughcompoundswhichinterruptthesedynamic
endocrine feedback processes are generallythought
to act only during the time of exposure, there is
suggestive evidence that prenatal exposure to cer-
tain pesticides may alter subsequent functioning of
the hypothalamus and pituitary (3,24).
The effects of xenobiotics on ovum and sperm
transportarepoorlyunderstood. Furtherresearchis
needed to define the physiological and cellularmech-
anisms controlling these processes. At the present
time the major factors associated with disordered
sperm, ovum and conceptus transport appear to be
sequelae of uterine and tubal infections and endo-
metriosis.
Fertilization to Implantation
The complex endocrine, cellular and molecular
events involved in mammalian gamete recognition,
sperm penetration, nuclear decondensation and pro-
nuclear interaction are presently under investiga-
tion. The effects of xenobiotics on these processes
remain poorly characterized.
The site of implantation in the uterus plays a
major role in determining the risk ofmorbidity and
mortality during pregnancy. Xenobiotic influences
on the mechanism or site of implantation in pri-
mateshavenotbeenexplored. Evidencefromrodent
systems suggests thatfactors alteringtubaloruter-
ine motility can alter the spacing of implantation
sites as well as endometrial preparation forimplan-
tation (5,25,26).
Placentation to Parturition
Early placental development requires an endo-
metriumnormally prepared and capable ofsupport-
ing implantation. Several xenobiotics have been
demonstrated to decrease the uterotropic effects of
endogenous or exogenous steroids and could alter
placentation. These compounds include polycycic
aromatic hydrocarbons and barbiturates as well as
certain antibiotics and anticonvulsants (3,24,27,28).
Factors altering fetal organogenesis, fetal and
placental growth and maturation have been and
continue to be characterized by fetal pharmacolo-
gists and teratologists and will not be considered
here.
Parturition
Present evidence suggests that fetal hormonal
signals control the onset of labor, and drugs that
advance and retard the onset of labor have been
identified (29). After the onset of labor, factors
influencing electrical activity of myometrium and
electromechanical coupling producing uterine con-
tractions, together with bony structure and degree
ofextensibility ofsoft tissues along the birth canal,
determine the progression oflabor. Although DES
has been demonstrated to alter the anatomy ofthe
vagina and cervix, in general the influence of
xenobiotics on uterine activity or the birth canal
remains uncharacterized.
Postnatal
Postnatal events includingdelivery ofthe placen-
ta, uterine involution, fetal and maternal physio-
logic and metabolic adaptation and lactation, all
focus on resolution of the pregnancy and support
and maintenance ofthe newly born infant. Factors
influencingendometrial development, site ofimplan-
tation and depth ofplacental penetration into endo-
metrium and myometrium will influence the deliv-
ery of the placenta. It is not known if xenobiotics
influence primate placentation.
Lactation is discussed by Rogan (30); suffice it to
say that a variety ofxenobiotics can be excreted in
breast milk. Additionally, xenobiotics which alter
the secretion of breast milk have been identified.
Reproductive Senescence
Reproductive senescence represents the failure
of one or more of the organs, or physiological con-
trol mechanisms along the reproductive cycle. Evi-
dence from clinical observations of women as well
as studies of experimental animals suggests that
declining fertility with age represents combined
failure ofboth the uterus and ovaries. Menopause,
a clinical diagnosis, represents a specific subevent
inreproductive senescence, the failure oftheovary.
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FIGURE 2. Relationship between oocyte number and age in
women. The inset indicates the relationship between age,
oocyte numberand menopause. Reprinted from Mattison and
Ross (24) with permission.
Present evidence suggests that the hypothalamus
and pituitary remain functional until late in life,
long after menopause.
Menopause, a clinical syndrome reflecting dimin-
ished ovarian estrogen production, occurs when the
ovary is depleted ofoocytes (Fig. 2). Factors asso-
ciated with premature menopause appear to act by
destroying oocytes (3,4,7-9,16,31,32). Additionally,
factors which decrease the formation of oocytes in
the fetus are also associated with premature ovar-
ianfailure (15,32). Thesedatasuggestthatxenobiotics
which block oogenesis or destroy oocytes will pro-
duce premature ovarian failure orpremature meno-
pause.
Mechanisms of Reproductive
Toxins
In the overview offemale reproductive physiolo-
gy, we identified several reproductive toxins. To
understand why these compounds are toxic, we
need to define both their site and mechanism of
action. One useful scheme for classifying reproduc-
tive toxins is illustrated on Figure 3. In this section
Iwillusethis schemetoclassifytheprototype repro-
ductive toxins previously discussed (see Table 2).
Diethylstilbestrol
DES clearly produces some of its effects by vir-
tue ofits estrogenic activity (3,4,33,34). Additional
evidence suggests that the carcinogenic and muta-
genic activity ofDES mayreside in reactive metab-
olites generated by microsomal monooxygenases or
peroxidases (35-37).
FIGURE 3. Mechanisms of reproductive toxicity. Reprinted
from Mattison (4) with permission.
Polycyclic Aromatic Hydrocarbons
The polycyclic aromatic hydrocarbons produce
their adverse reproductive effects in two ways.
Ovarian toxicity and oocyte destruction is produced
by reactive electrophilic metabolites generated by
metabolism of the parent hydrocarbon (3,38-40).
Polycyclichydrocarbons are alsoinducers ofhepatic
enzymesincludingmicrosomalmonooxygenasesand
transferases involved in steroid metabolism and
clearance (28).
Azathioprine and 6-Mercaptopurine
The purine analogs azathioprine and 6-mercap-
topurine appear to exert their adverse effects on
ovarian development through structural similarity
(41,42). As the sensitivity of different stages of
oogenesis to these purine analogs has not been
quantitated, it is not known ifthe major effect is on
primordial germ cells, oogonia or oocytes.
Galactose
Ovarian failure in women with galactosemia due
to deficiencies in uridyltransferase and apparently
normalovarianfunctioninwomenwithgalactosemia
due to kinase deficiency suggest that toxicity is due
togalactose-1-phosphate(16). Theabsenceofovarian
toxicity in animals exposed postnatally favors a
mechanism involving structural similarity but does
not rule out the formation ofa reactive metabolite.
Halogenated Polycyclic Hydrocarbons
This large class ofcompounds appears to disrupt
reproductive function by two mechanisms: induc-
tion ofhepaticmonooxygenases and structural simi-
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Table 2. Mechanisms of action of selected reproductive toxins.
Direct acting Indirect acting
Compound Structural similarity Chemical reactivity Metabolism Enzyme alteration
Diethylstilbesterol * *
Polycyclic aromatic hydrocarbons * * *
Purine analogs
Azathioprine 6-mercaptopurine *
Galactose * * *
Halogenated polycyclic hydrocarbons
DDT *
PCB *
PBB * *
Phytoestrogens *
Barbiturates, anticonvulsants *
Nicotine *
larityto estrogens either directly orfollowingmetab-
olism.
Barbiturates, Anticonvulsants
Certain drugs, notably barbiturates and many
anticonvulsants, are good inducers of the hepatic
enzymes responsible for steroid clearance. Stimula-
tion of clearance appears to be the major mecha-
nism by which these compounds decrease the effec-
tiveness of oral contraceptives.
Nicotine
The effect ofnicotine on uterine and tubal motil-
ity in the primate appears to result from stimula-
tion of nicotinic receptors. This has two effects:
release of epinephrine which mimics the effect of
nicotine on human utero-tubal motility and stimula-
tion of release of oxytoxin from the posterior pitu-
itary which also alters uterine motility (5).
This briefoverview ofmechanisms indicates that
reproductive toxins produce theiradverse effects in
a wide variety ofways. Complete understanding of
both site and mechanism of action of reproductive
toxins will be necessary to extrapolate from exper-
imental animal studies to evaluation ofhuman risk.
Fortunately a detailed site and mechanism-specific
approach will also allow the wide use ofa variety of
animalmodelsystemstailored directlytothespecific
physiological and toxicological mechanisms being
explored.
Ovarian Toxicity
In this section we will explore the effects of
oocyte destruction on fertility and age of ovarian
failure and then consider an experimental animal
model system which we have used to investigate
mechanisms of oocyte destruction.
In humans and experimental animals ovarianfail-
ure occurs when the ovary is depleted of oocytes.
The age at which the ovary is depleted ofoocytes is
controlled by several factors: the number ofoocytes
formed during oogenesis and the rate ofoocyte loss
due to ovulation, failure offolliculogenesis, atresia,
and toxicity. In general, the number ofoocytes lost
due to ovulation is small, and in the normal ovary
atresia and failure to complete folliculogenesis
account for most oocyte loss. However, after treat-
ment with ovarian toxins oocyte loss can be quite
extensive.
Oogenesis and Folliculogenesis
The ovary forms from two separate components:
primordial germ cells which originate in an extra
embryonic region nearthe yolk sac and the urogen-
ital ridge (24). During organogenesis differential
tissue growth brings the primordial germ cells into
the hindgut region ofthe embryo. Primordial germ
cells then migrate to the urogenital region from the
hindgut. Primordial germ cells proliferate from the
time they differentiate until they form oogonia, the
stem cells for oocytes.
In the ovary, oogonia proliferate in syncytical
groups until folliculogenesis begins. At the onset of
folliculogenesis a group of oogonial cells will cease
proliferation, the syncytial bridges between oogo-
nial cells are lost and the oogonia enter meiosis.
During this period the follicle complex is formed.
The follicle complex is the smallest functional
unit of the ovary, consisting of oocyte, granulosa
cells, basement membrane and thecal cells. Oocytes
require this follicular complex for support. Those
oocytes which are not a part ofa follicular complex
following the completion offolliculogenesis are lost
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through extrusion from the surface ofthe ovary or
cell death within the ovary. Xenobiotic or endoge-
nous compounds which block oogenesis or folliculo-
genesis will decrease the number of oocytes.
Follicular Growth, Ovulation, Atresia
After sexual maturation, three types offollicular
complexes are found in the ovary; resting or pri-
mordial follicles, growing follicles and preovulatory
follicles (Fig. 4). These three general types offolli-
cle complexes are distinguished on the basis of
oocyte size, zona pellucida size, and number of
granulosacells. Thisclassificationisimportantbecause
follicle complexes of different size have different
susceptibility to ovarian toxins, and because toxic-
ity to different follicle types may have different
effects on fertility and age of ovarian failure.
Follicular growth requires recruitment of folli-
cles from the resting pool into the growing pool.
The mechanisms involved in recruitment are poorly
understood at the present time. However, the
recruitment process may not be completely depen-
dent on gonadotropins. Further growth and ulti-
mate ovulation of the oocyte from the follicle com-
plex requires the appropriate local concentrations
ofgonadotropins and steroid hormones produced by
dynamic interactions between the ovary, hypothal-
amus and pituitary. Followingovulation, thefollicle
complex differentiates into the corpus luteum.
Follicle complexes recruited into the growing
pool which do not ovulate undergo atresia, the
death of the follicle complex. Atresia can occur at
any point along the pathway from recruitment to
ovulationand occurs because concentrations ofgonad-
otropins and steroid hormones within that follicle
complex cannot support its continued proliferation.
Differential Follicular Toxicity
Inexperimentalanimalsandhumans, folliclecom-
plexes have differing sensitivity to ovarian toxins
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depending on the strains, species, compound and
dose schedule used. In rodents single treatment
with polycyclic aromatic hydrocarbons, alkylating
agents orionizingradiationdestroys predominantly
the resting or primordial follicles (14,31,32,44-46).
Inwomenandnonhumanprimates, ionizingradiation
and treatment with alkylating agents has its major
effect on growing and preovulatory follicle com-
plexes (7-9,31,32,44). Mechanisms underlying dif-
ferential follicle complex sensitivity are not under-
stood.
Oocyte Destruction and Fertility
Preovulatory Follicle Complex
Destruction
In women and nonhuman primates alkylating
agents and ionizing radiation destroys growing and
preovulatory follicles. As this includes the follicle
complex(es) destined to ovulate, this decreases fer-
tility immediately during the period of exposure
(Fig. 5). Additionally, destruction of preovulatory
follicle complexesdestroysthemajorsourceofovar-
ian estrogen synthesis, producing postmenopausal
symptoms.
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FIGURE 4. Follicle complex classification scheme. Reprinted
from Pedersen and Peters (43) with permission.
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FIGURE 5. Effect of ovarian toxins on fertility. The cross-
hatched area represents the period of ovotoxin exposure:
(-) the expected fertility; (--) the normalfertility in absence
of toxin exposure.
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The dose of cyclophosphamide required to pro-
duce permanent amenorrhea varies with age (Table
3). Women treated with substerilizing doses of
cyclophosphamide generally resume menses within
18 months following the last treatment course.
Resumption ofmenses is preceded by loss ofmeno-
pausalsymptoms, heraldingincreasingovarianestro-
gen synthesis. The long delay between cessation of
treatment and resumption of menses is not com-
pletely understood. However, it does notreflect the
length of time necessary for follicle complexes to
grow to preovulatory size as women with hypo-
gonadotropic hypogonadism can ovulate within 14
days of treatment (24).
Growing Follicle Complex Destruction
At the present time it is not known if there are
ovarian toxins which act only on growing follicle
complexes. If such compounds did exist, however,
their effect on fertility would be somewhat delayed.
Existing preovulatory follicles would have to be
exhausted before the antifertility effects would be
observed (Fig. 5). In primates the length of this
delay would be rather short since the follicle des-
tined to ovulate is chosen from the growing pool
between 7 and 12 days prior to ovulation (48). In
practice this suggests that it may not be possible to
differentiate between ovarian toxins acting only on
growing follicles and those acting only on preovula-
tory follicles.
Destruction of Resting Follicle
Complexes
Xenobiotics which destroy resting follicle com-
plexes only without altering recruitment, follicular
growth or ovulation would have no effect on fertil-
ityuntilallthesmallfolliclecomplexesweredestroyed
(Fig. 5). At that point the absence of follicles for
recruitment into the growing pool would be fol-
lowed by depletion of the number of growing folli-
cles and a subsequent failure to form preovulatory
follicles. Xenobiotics which destroy only resting
follicles would be silent reproductive toxins only
identifiable by oocyte quantitation or age of meno-
pause.
Table 3. Dose of cyclophosphamide required to produce
permanent amenorrhea.a
Age Total dose, g
20-29 20.4
30-39 9.3
40-49 5.2
aData from Koyama et al. (47).
Follicle Destruction and Ovarian
Failure
Oocyte destructionbyxenobiotics orionizingradi-
ation is associated with premature ovarian failure.
As a first approximation it therefore seems reason-
able to assume that exposures which decrease the
age ofmenopause, the clinicalmanifestation ofovar-
ian failure, do so by oocyte destruction.
The age of menopause is directly accessible in
either longitudinal, cross section, or case control
studies and can rapidly address one facet of repro-
ductive toxicity. One exposure whichhas beendem-
onstrated to decrease the age of menopause is
smoking (Fig. 6). Several well-designed epidemio-
logical studies have demonstrated an earlier age of
menopause in smoking women when compared to
controls (5). The study by Jick et al. shown in
Figure 6 demonstrates an inverse dose-response
relationship between the number ofcigarettes con-
sumed and the age of menopause, suggesting that
increasing exposure increases the extent of oocyte
destruction (49).
The component of cigarette smoke responsible
for oocyte destruction in smokers has not been
identified. Prime suspects include polycyclic aro-
matic hydrocarbons and protein pyrolysis products
(5), compounds demonstratingtoxic, mutagenic and
carcinogenicpropertiesinseveralbioassaysystems.
We have focused on polycyclic aromatic hydrocar-
bons and have begun to explore the mechanism of
oocyte destruction by these compounds.
Animal Models for Ovarian Failure
Polycyclic aromatic hydrocarbons (PAH) like
benzo(a)pyrene (BP) and alkylating agents like
100
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FIGURE 6. Relationship between cigarette consumption and
age ofmenopause: (left) women in the United States; (right)
women in seven European countries. Data from Jick et al.
(49); figure reprinted from Mattison (3) with permission.
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cyclophosphamidedestroyfolliclecomplexesinmouse
ovaries. Using this model system we are exploring
the age dependence offollicle complex destruction,
the role of metabolic activation in follicle complex
destruction, the role ofdetoxification infollicle com-
plex destruction, and strain and species differences
in sensitivity to follicle complex destruction.
Using PAH as probe molecules these investiga-
tionshave demonstrated thatfollicle complex destruc-
tionrequires metabolism ofthe parent compound to
areactive intermediate. Experiments utilizing bilat-
eral and unilateral intraovarian injection have dem-
onstrated that ovarian metabolism is sufficient to
produce the reactive ovotoxic matabolites. These
data suggest that differences in ovarian metabolic
processing of polycyclic hydrocarbons may corre-
late with age, strain orspecies differences in follicle
toxicity.
Our initial efforts to explore the relationship
between follicle toxicity and ovarian PAH metabo-
lism focused on ovarian AHH activity. Differences
in inducibility of hepatic aryl hydrocarbon [benzo-
(a)pyrene] hydroxylase (AHH, EC 1.14.14.1) activ-
ity are associated with differences in sensitivity to
PAH toxicity, mutagenicity and carcinogenicity in
several bioassay systems (50,51). Using a murine
model system in which inducibility ofovarian AHH
activity was inherited as an autosomal dominant
trait, we found that resistance to oocyte destruc-
tion was inherited as a polygenic trait. These and
other data demonstrate that sensitivity to follicle
destruction by PAH although dependent on ovarian
metabolism is not linked to the Ah locus and does
not correlate with ovarian AHH activity (52,53).
More recent investigations using high pressure
liquid chromatographic analysis of benzo(a)pyrene
metabolites produced bymurine ovarianmicrosomes
suggests that metabolism in the 7,8,9,10-region of
BP may be a better measure of the ability of
ovarian enzymes to form reactive ovotoxic metabo-
lites (54,55). These data correlate well with exper-
iments demonstrating that the 7,8-dihydrodiol-BP
is more ovotoxic than BP, suggesting that one
follicle toxin generated by ovarian enzymes is the
7,8-dihydrodiol-9,10-oxide-BP, and are also consis-
tent with an extensive literature indicating that an
ultimate mutagenic and carcinogenic metabolite of
BP is the 7,8-diol-9,10-oxide.
Conclusions
Xenobiotic compounds can interrupt female fer-
tility at several different sites in the reproductive
pathway and by one or more mechanisms. One
rapidly ascertainable form of reproductive toxicity
is premature or early ovarian failure. Evidence
from clinical studies demonstrates that follicle de-
struction by alkylating agents and other antitumor
cytostatics or ionizing radiation produces prema-
ture ovarian failure. The demonstration of early
cigarette dose-dependent ovarian failure suggests
that the age of menopause may be one sensitive
indicator ofexposure to ovarian toxins. Analysis of
the age of menopause in exposed populations in
conjunction with experimental animal model stud-
ies will help define the utility of this reproductive
end point.
Experimentalanimal modelsystemswillalsohelp
define the mechanism ofovarian toxicity. Exploita-
tion ofmurine models has demonstrated that ovar-
ian metabolism plays a major role in the ovarian
toxicity of polycyclic aromatic hydrocarbons. The
use ofthis or other animal model systems may help
definetheovariantoxicityofdrugsorotherxenobiotic
compounds. Certainly the ovarian toxicity of com-
plex mixtures of xenobiotic compounds is directly
accessible in animal model systems.
Safe, controlled reproduction with the formation
of healthy offspring when fertility is desired is the
major goal ofevery couple in the world. Because of
this the identification and characterization ofxeno-
biotics which impair reproduction is a crucial issue.
Continued and expanded interaction between clini-
cians, toxicologists, reproductive biologists and epi-
demiologists is essential to approach this goal of
healthy regulated reproduction essential to human
kind.
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